Coverage, interviews, and appearances
PRESS
Where CEP's work is discussed by others, and where our researchers present it.
For journalists, conference organizers, and event hosts interested in the economics of psychedelic access, Elliot Marseille is available for interviews, articles, and speaking engagements.
Request an Interview or Speaking Engagement
In the News
-
The Twelve-Thousand-Dollar Question: Who Picks Up The Tab For Psychedelics?
Date: 19-Feb-26
Publisher: Health Affairs -
Decriminalizing Psychedelics: Should hallucinogenic drugs be legalized?
Date: 15-Dec-23
Publisher: CQ Researcher -
Views Psychedelic-assisted therapy, coming to a health plan near you
Date: 19-Dec-22
Publisher: Employee Benefit News -
Effect of MDMA price on cost-effectiveness of MDMA therapy
Date: 16-Dec-22
Publisher: Lucid News -
Health Insurance and the economics of psychedelic therapies
Date: 7-Dec-22
Publisher: STAT News -
Psychedelics: Threat Or Opportunity For Big Pharma?
Date: 27-Oct-22
Publisher: Medium -
Will Medical Insurers Agree to Cover Psychedelic Trips?
Date: 17-Oct-22
Publisher: Bloomberg News -
Drug companies are investing big in psychedelics, but can they engineer out the trip?
Date: 6-Mar-22
Publisher: C&EN -
Why 2020 Is a Banner Year for Drug Decriminalization—And What It Means for Public Health
Date: 5-Nov-20
Publisher: Vogue -
Study: MDMA-Assisted Psychotherapy Will Be More Cost-Effective than Other Treatments for PTSD
Date: 14-Oct-20
Publisher: psychedelic finance
Interviews and Podcasts
-
The Economics of Psychedelics, with Elliot Marseille, DrPH, MPP
Date: 24-May-24
Publisher: Psychedelics Today -
Global Initiative for Psychedelic Science Economics (GIPSE)
Date: 14-Nov-22
Publisher: Psychedelic Alpha